Cardinal Health’s Outperform Rating Reaffirmed at Credit Suisse (CAH)
Cardinal Health (NYSE:CAH)‘s stock had its “outperform” rating reiterated by stock analysts at Credit Suisse in a report issued on Tuesday. They currently have a $80.00 price target on the stock, up from their previous price target of $76.00. Credit Suisse’s price target suggests a potential upside of 13.83% from the company’s current price.
Cardinal Health (NYSE:CAH) traded up 0.47% during mid-day trading on Tuesday, hitting $70.61. 1,600,106 shares of the company’s stock traded hands. Cardinal Health has a 52 week low of $49.65 and a 52 week high of $74.40. The stock has a 50-day moving average of $70.29 and a 200-day moving average of $69.28. The company has a market cap of $24.022 billion and a price-to-earnings ratio of 70.28.
Cardinal Health (NYSE:CAH) last released its earnings data on Monday, August 4th. The company reported $0.83 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was down 9.9% on a year-over-year basis. Analysts expect that Cardinal Health will post $4.25 EPS for the current fiscal year.
A number of other firms have also recently commented on CAH. Analysts at Zacks reiterated a “neutral” rating on shares of Cardinal Health in a research note on Tuesday. They now have a $74.00 price target on the stock. Separately, analysts at Leerink Swann raised their price target on shares of Cardinal Health from $78.00 to $84.00 in a research note on Tuesday. Finally, analysts at Mizuho reiterated a “buy” rating on shares of Cardinal Health in a research note on Monday. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $78.03.
In other Cardinal Health news, CAO Stuart G. Laws sold 21,266 shares of the company’s stock in a transaction that occurred on Thursday, July 24th. The shares were sold at an average price of $72.50, for a total transaction of $1,541,785.00. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.